References

  1. Marret H, Lhommé C et al. French recommendations for ovarian cancer management during pregnancy. Gynecol Obstet Fertil. 2009 Sep;37(9):752-63. This article on PubMed

  2. Yazbek J, Salim R, Woelfer B et al. The value of ultrasound visualization of the ovaries during the routine 11-14 weeks nuchal translucency scan. Eur J Obstet Gynecol Reprod Biol. 2007 Jun;132(2):154-8. This article on PubMed

  3. Ardaens Y, Coquel P. : Imagerie des kystes et des tumeurs de l'ovaire. Encyclopédie. Médico-Chirurgicale : Gynécologie. 2000; 680-A-26

  4. Aggarwal P, Kehoe S. Ovarian tumours in pregnancy: a literature review. Eur J Obstet Gynecol Reprod Biol. 2011 Apr;155(2):119-24. This article on PubMed

  5. Okamoto Y et al. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR. J Magn Reson Imaging. 2007; 26:94-9. This article on PubMed

  6. Telischak NA, Yeh BM, Joe BN et al. MRI of adnexal masses in pregnancy. AJR Am J Roentgenol. 2008;191:364. This article on PubMed

  7. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinoma in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol. 2003; 27:985-993. This article on PubMed

  8. O'Connell JT, Tomlinson JS et al. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol. 2002 Aug;161(2):551-64. This article on PubMed

  9. Stewart CJ, Tsukamoto T et al. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour. Pathology. 2006;38:534-8. This article on PubMed

  10. Thomas G. Traitement des tumeurs de l’ovaire à potentiel de malignité restreinte. Directives cliniques de la SOGC. 2000 Janvier:85